New data presented at AD/PD 2019 demonstrated the feasibility and validity of conducting automated, verbal recall tasks on participants’ own devices. This research has implications for recruitment and monitoring in Alzheimer’s disease trials.
At AD/PD 2019 we showed that automated, electronic cognitive testing is acceptable and feasible for patients presenting to clinic with Parkinson’s disease.
Traditional cognitive measures struggle to demonstrate when a participant is compensating for their deficits. At AD/PD 2019 we shared new data on how to overcome this issue: deriving cognitive load from voice data collected on participants’ own devices, and in their own homes.